“Home DNA-testing company 23andMe is laying off about 100 people, or 14% of its staff, on Thursday, in the wake of declining sales.
The layoffs include the operations teams, which were focused on the company’s growth and scaling efforts, as well as other teams. In the coming months, the company plans to tighten its focus on the direct-to-consumer business and its therapeutics arm while scaling back its clinical studies arm.”
Those of us who’ve been watching the industry have seen this coming for a while. It’s why companies move into other arenas – like Ancestry going into health. Keep an eye on this though because this is one of the larger companies who is having to do this.